Skip to content

Cash ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×0.0×
Myriad Genetics logo
Myriad GeneticsMYGN
+0.3×
Labcorp Holdings logo
Labcorp HoldingsLH
0.4×+0.2×
Quest Diagnostics logo
Quest DiagnosticsDGX
0.2×0.0×
NeoGenomics logo
NeoGenomicsNEO
1.7×+0.5×
Natera, Inc. logo
Natera, Inc.NTRA
1.9×-0.7×

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Calculated from Fulgent Genetics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s cash ratio?
Fulgent Genetics, Inc. (FLGT) reported cash ratio of 0.3× in Q1 2026.
How has Fulgent Genetics, Inc.'s cash ratio changed year-over-year?
Fulgent Genetics, Inc.'s cash ratio decreased by 74.6% year-over-year, from 1× to 0.3×.
What is the long-term trend for Fulgent Genetics, Inc.'s cash ratio?
Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s cash ratio has grown at a -2.5% compound annual growth rate (CAGR), from 0.7× to 0.6×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.